Last reviewed · How we verify

NCT05485428: HH4P

The HIIT-Home4Parkinson's Study

Completed NA Last updated 9 May 2024
What this trial tests

NA trial testing High-intensity interval training in Parkinson's Disease in 13 participants. Completed in 1 May 2024.

Timeline
1 September 2023
Primary endpoint
25 April 2024
1 May 2024

Quick facts

Lead sponsorUniversity of Plymouth
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment13
Start date1 September 2023
Primary completion25 April 2024
Estimated completion1 May 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Plymouth

Who can join

18 and older, any sex, with Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to investigate the practicality and utility of home-based high-intensity interval training (HIIT) by undertaking a previously developed, novel home-based HIIT intervention for people with Parkinson's (PwP).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Home-Based High-Intensity Interval Training for People With Parkinson's: A Randomized, Controlled, Feasibility Trial.
    Harpham C, Gunn H, Marsden J, Bescos-Garcia R, et al · · 2025 · cited 3× · PMID 40661734 · DOI 10.1002/hsr2.71024
  2. Home-based high-intensity interval training for people with Parkinson's: Protocol for the HIIT-Home4Parkinson's randomized, controlled feasibility study.
    Harpham C, Gunn H, Marsden J, Bescos Garcia R, et al · · 2024 · cited 3× · PMID 38192731 · DOI 10.1002/hsr2.1800

Verify or expand the search:

Other trials of High-intensity interval training

Trials testing the same drug.

Other recruiting trials for Parkinson's Disease

Currently open trials in the same condition.

Other University of Plymouth trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05485428.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing